Bayer and Boehringer Ingelheim outlined plans to increase access to their clinical trial data. Both are using ClinicalStudyDataRequest.com to share clinical study reports and de-identified patient level-data with reseachers upon request. GlaxoSmithKline ($GSK), Novartis ($NVS), Roche ($RHHBY) and Sanofi ($SNY) also use the portal to manage data requests. Bayer release | Boehringer release